早期使用羟基脲对镰状细胞贫血患儿具有神经保护作用。
Early hydroxyurea use is neuroprotective in children with sickle cell anemia.
机构信息
Division of Hematology/Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Division of Hematology, Cancer & Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
出版信息
Am J Hematol. 2022 Oct;97(10):E368-E370. doi: 10.1002/ajh.26664. Epub 2022 Jul 26.
PMID:35836401
Abstract
Children with sickle cell disease (SCD) who began hydroyxurea before age five years scored no differently on a measure of cognitive funciton than age, sex, and race-matched unaffected peers.
摘要
五岁前开始使用羟基脲治疗的镰状细胞病 (SCD) 患儿在认知功能测量上的得分与年龄、性别和种族匹配的未受影响的同龄人没有差异。
Zotero 插件